Invention Grant
- Patent Title: Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
-
Application No.: US17531885Application Date: 2021-11-22
-
Publication No.: US11306314B2Publication Date: 2022-04-19
- Inventor: Brian Bettencourt , William Querbes , Kevin Fitzgerald , Maria Frank-Kamenetsky , Stuart Milstein , Svetlana Shulga Morskaya
- Applicant: Alnylam Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Maria Laccotripe Zacharakis; Deborah L. Nagle
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K31/713 ; A61K31/7105 ; C12Q1/68
Abstract:
The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the ANGPTL3 gene, as well as methods of inhibiting expression of ANGPTL3 and methods of treating subjects having a disorder of lipid metabolism, such as hyperlipidemia or hypertriglyceridemia, using such dsRNA compositions.
Public/Granted literature
- US20220073924A1 ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF Public/Granted day:2022-03-10
Information query
IPC分类:
